Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.34 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.30 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27816963 | 1.00 | AOC3 (0.36) | AOC3EPHX2NSD2MCHR1SCN9A | |
| SCHEMBL27702058 | 1.00 | AOC3 (0.36) | AOC3EPHX2NSD2MCHR1SCN9A | |
| Bromide SCHEMBL4734510 | 0.99 | AOC3 (0.36) | AOC3EPHX2NSD2MCHR1SCN9A | |
| SCHEMBL6580186 | 0.83 | AOC3 (0.36) | AOC3MEN1KMT2AOPRM1ADRB2 | |
| SCHEMBL2347668 | 0.82 | EPHX2 (0.32) | AOC3EPHX2NSD2MCHR1CYP2C9 | |
| SCHEMBL27836477 | 0.80 | EPHX2 (0.38) | AOC3EPHX2NSD2MCHR1SCN9A | |
| SCHEMBL2337792 | 0.80 | EPHX2 (0.38) | AOC3EPHX2NSD2MCHR1SCN9A | |
| SCHEMBL27836479 | 0.80 | EPHX2 (0.38) | AOC3EPHX2NSD2MCHR1SCN9A | |
| SCHEMBL907710 | 0.78 | EPHX2 (0.38) | AOC3EPHX2SCN9ACYP19A1S1PR3 | |
| SCHEMBL19370305 | 0.76 | SLC6A4 (0.42) | SCN9ACYP2C9CYP2C19OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114763329-B | Purification method of citalopram key intermediate | ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-114763329-A | Method for purifying citalopram key intermediate | 浙江华海药业股份有限公司 | 2022-07-19 | — | — | CN | claimed |
| EP-2061753-A1 | METHOD FOR MANUFACTURE OF ESCITALOPRAM | H.Lundbeck A/S (DK) | 2009-05-27 | — | — | EP | claimed |
| WO-2009033488-A1 | METHOD FOR MANUFACTURE OF ESCITALOPRAM | H. LUNDBECK A/S (DK) | 2009-03-19 | — | — | WO | claimed |
| CN-114763329-B | Purification method of citalopram key intermediate | ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-114763329-B | Purification method of citalopram key intermediate | ZHEJIANG HUAHAI PHARMACEUTICAL CO.,LTD. (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-114763329-A | Method for purifying citalopram key intermediate | 浙江华海药业股份有限公司 | 2022-07-19 | — | — | CN | disclosed |
| CN-114763329-A | Method for purifying citalopram key intermediate | 浙江华海药业股份有限公司 | 2022-07-19 | — | — | CN | disclosed |
| EP-1581483-B1 | A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR i S- /i OR i R- /i CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, i R- /i CITALOPRAM AND/OR i S- /i CITALOPRAM | LUNDBECK & CO AS H (DK) | 2012-06-06 | — | — | EP | disclosed |
| EP-2061753-A1 | METHOD FOR MANUFACTURE OF ESCITALOPRAM | H.Lundbeck A/S (DK) | 2009-05-27 | — | — | EP | disclosed |
| WO-2009033488-A1 | METHOD FOR MANUFACTURE OF ESCITALOPRAM | H. LUNDBECK A/S (DK) | 2009-03-19 | — | — | WO | disclosed |
| WO-2008059514-A2 | PROCESS FOR PREPARING ESCITALOPRAM | CADILA HEALTHCARE LIMITED (IN) | 2008-05-22 | — | — | WO | disclosed |
| EP-1534654-A1 | METHOD FOR THE SEPARATION OF INTERMEDIATES WHICH MAY BE USED FOR THE PREPARATION OF ESCITALOPRAM | H. LUNDBECK A/S (DK) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004056754-A1 | A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR S- OR R- CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, R-CITALOPRAM AND/OR S-CITALOPRAM | H. LUNDBECK A/S (DK) | 2004-07-08 | — | — | WO | disclosed |
| WO-2004056754-A1 | A PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM DIOL AND/OR S- OR R- CITALOPRAM DIOLS AND THE USE OF SUCH DIOLS FOR THE PREPARATION OF RACEMIC CITALOPRAM, R-CITALOPRAM AND/OR S-CITALOPRAM | H. LUNDBECK A/S (DK) | 2004-07-08 | — | — | WO | disclosed |
| EP-1412341-A1 | PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM AND/OR S- OR R-CITALOPRAM BY SEPARATION OF A MIXTURE OF R- AND S-CITALOPRAM | H. Lundbeck A/S (DK) | 2004-04-28 | — | — | EP | disclosed |
| WO-2004014821-A1 | METHOD FOR THE SEPARATION OF INTERMEDIATES WHICH MAY BE USED FOR THE PREPARATION OF ESCITALOPRAM | H. LUNDBECK A/S (DK) | 2004-02-19 | — | — | WO | disclosed |
| WO-2003000672-A1 | PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM AND/OR S- OR R-CITALOPRAM BY SEPARATION OF A MIXTURE OF R- AND S-CITALOPRAM | H. LUNDBECK A/S (DK) | 2003-01-03 | — | — | WO | disclosed |
| EP-1228056-A2 | METHOD FOR THE PREPARATION OF CITALOPRAM | H. LUNDBECK A/S (DK) | 2002-08-07 | — | — | EP | disclosed |
| WO-2000012044-A2 | METHOD FOR THE PREPARATION OF CITALOPRAM | H. LUNDBECK A/S (DK) | 2000-03-09 | — | — | WO | disclosed |